What Does Atrial Fibrillation With RVR Look Like?

Atrial fibrillation with rapid ventricular response, commonly shortened to AF with RVR, looks like an irregular heartbeat racing at 100 beats per minute or higher, often reaching 130 to 170 or more. On an ECG, the hallmark is a chaotic baseline with no organized atrial waves and irregularly spaced QRS complexes arriving far too quickly. In the person experiencing it, the picture is more visceral: a pounding or fluttering chest, breathlessness, lightheadedness, and sometimes a feeling that something is seriously wrong. The “RVR” part is what makes this version of atrial fibrillation particularly dangerous, because it means the electrical chaos in the upper chambers is spilling through to the ventricles fast enough to compromise the heart’s ability to pump effectively.

What You Feel During an Episode

The symptoms of AF with RVR overlap with those of slower atrial fibrillation but tend to be more intense and harder to ignore. Palpitations are the most recognizable complaint: an awareness of your heart beating fast, irregularly, or both. Some people describe a “fish flopping” or “bag of worms” sensation in the chest. Shortness of breath often accompanies the rapid rate because the heart doesn’t have time to fill properly between beats, reducing the amount of blood pumped with each contraction. Dizziness, near-fainting, and fatigue round out the most common experiences. In a large Korean registry, AF-related symptoms were reported by roughly 59% of patients whose ventricular rate was rapid, compared with about 41% of those whose rate was controlled, confirming that faster rates mean more noticeable distress.¹

Chest pain can also occur, even in people without coronary artery disease, because the racing heart demands more oxygen than usual while simultaneously delivering less. Some people feel the need to urinate frequently during an episode, a quirk caused by the heart releasing a hormone (atrial natriuretic peptide) when the atria are stretched by the abnormal rhythm. And a subset of people, particularly those with longstanding AF, feel very little at all despite dangerously fast rates. These “silent” presentations are one reason AF with RVR sometimes gets caught only when someone shows up with a different complaint like ankle swelling or unexplained fatigue.

What a Clinician Sees at the Bedside

From the outside, a person in AF with RVR often looks anxious, pale, or clammy. When a nurse or doctor checks a pulse, two things stand out: the rate is high, and the rhythm is completely irregular, with no discernible pattern between beats. One classic bedside finding is a “pulse deficit,” meaning the pulse felt at the wrist is slower than the heartbeat counted through a stethoscope over the heart. This happens because some beats are so weak, firing before the ventricle has had time to fill, that they don’t generate enough pressure to reach the wrist.² Blood pressure may be low, and if the rate is very fast or the person has underlying heart disease, signs of heart failure like lung crackles or neck vein distension can appear within hours.

On a cardiac monitor, the rhythm strip shows the classic AF pattern: an undulating, irregular baseline instead of clean P waves, with QRS complexes arriving at unpredictable intervals. What separates RVR from controlled AF is simply the speed. A controlled atrial fibrillation rhythm might show QRS complexes at 70 or 80 per minute. In RVR, those same complexes are crammed together at 130, 150, sometimes over 170 per minute, making the strip look dense and disorganized.

Why the Rate Spins Out of Control

In normal atrial fibrillation, the AV node acts as a gatekeeper, filtering the hundreds of chaotic electrical signals coming from the atria and letting only a fraction through to the ventricles. When that gatekeeper is overwhelmed, the result is RVR. Several situations can tip the balance.

An emergency department study of 665 patients presenting with AF and a rapid rate found that only about 22% had “primary” AF, meaning the fast rate was the main problem. In roughly 78% of cases, a separate medical condition was pushing the heart rate up: heart failure, pneumonia, sepsis, thyroid storm, dehydration, or acute blood loss.³ This distinction matters enormously. Giving a rate-slowing drug to someone whose heart is racing because of a raging infection won’t fix the underlying problem; treating the infection will. That’s why emergency physicians spend as much time looking for the trigger as they do slowing the heart.

Common triggers for RVR in someone who already has AF include fever, alcohol use, stimulant drugs, caffeine in large amounts, recent surgery, uncontrolled pain, and missed doses of rate-controlling medication. New-onset AF can also debut with RVR, particularly when the first episode is triggered by a stressor like surgery or a severe illness. In that scenario, the AV node hasn’t yet adapted to filtering the erratic atrial signals, and the ventricles respond by racing.

How It Shows Up on an ECG

The ECG is the tool that turns suspicion into diagnosis. When a clinician interprets the tracing, several steps unfold simultaneously. First, they confirm the rhythm is truly AF and not another fast irregular rhythm like multifocal atrial tachycardia or atrial flutter with variable block. Then they look for danger signs: evidence of Wolff-Parkinson-White syndrome (wide, bizarre-looking QRS complexes suggesting electrical signals are bypassing the AV node), ST-segment changes that could indicate a heart attack, signs of enlarged heart chambers, or electrolyte abnormalities like potassium imbalances.⁴

The width and shape of the QRS complexes are especially important. In typical AF with RVR, the QRS complexes look narrow and normal-shaped; only the spacing between them is irregular and too close together. If the QRS complexes are wide or bizarre-looking, the clinician has to worry about whether the signals are traveling through an accessory pathway or whether the patient has a pre-existing bundle branch block. That distinction changes treatment dramatically, as discussed below.

Beyond the ECG itself, bedside ultrasound is sometimes used to check the diameter of the inferior vena cava, which gives a quick read on whether the patient is dehydrated or fluid-overloaded. Both conditions can drive RVR and both require different treatments.⁵

What Fast Rates Do to the Heart Over Time

A racing ventricle isn’t just uncomfortable; it’s mechanically inefficient. When the heart beats too fast, it doesn’t have time to fill between contractions, so each beat pumps less blood. Research on patients who were electrically cardioverted out of AF found that restoring a normal rhythm led to an increase in cardiac output of nearly a liter per minute, and those gains correlated with how much better patients felt afterward.⁶ That lost output during RVR is why people feel wiped out and short of breath.

If the fast rate persists for weeks to months without adequate control, the heart muscle itself can weaken, a condition called tachycardia-induced cardiomyopathy. The ventricle stretches, pumping function drops, and the person develops heart failure. The encouraging part of this diagnosis is that it’s largely reversible. A case report described a 61-year-old man admitted with AF at 130 to 150 beats per minute whose heart’s pumping fraction had fallen to just 10%. After rhythm was restored, pumping function improved to 40% within 48 hours and recovered to 62% at six months.⁷ A state-of-the-art review confirmed this pattern broadly: when the offending arrhythmia is eliminated, the cardiomyopathy reverses.⁸

There is one caveat. Some people carry genetic variants that make their hearts more vulnerable to rate-driven damage. A recent case report identified a novel gene variant (in a gene called ABCC9) that appeared to make a patient unusually susceptible to cardiomyopathy from AF, suggesting that not every case of heart muscle weakening during fast AF is purely mechanical. Some may reflect an underlying genetic predisposition.⁹

How It’s Treated When You Show Up at the Emergency Department

The first decision is binary: is the patient hemodynamically stable, or not? If blood pressure has crashed (systolic below 90), consciousness is altered, or there are signs of cardiogenic shock, the treatment is emergency electrical cardioversion, a synchronized shock delivered through pads on the chest to reset the rhythm. A study of critically ill ICU patients who developed AF with RVR and hemodynamic instability (heart rate at or above 130 with systolic blood pressure at or below 90, or a need for vasopressors) used direct-current cardioversion as the emergency intervention.¹⁰ That’s the most dramatic scenario and the easiest treatment decision.

For the majority of patients who are stable but symptomatic, the goal is rate control: slow the ventricular response with medication while figuring out and addressing the underlying trigger. The two most commonly used intravenous drugs are diltiazem (a calcium channel blocker) and metoprolol (a beta blocker), and the debate over which is superior has generated a surprising amount of research.

Diltiazem Versus Metoprolol

The evidence here is nuanced enough to be worth unpacking, because both drugs are widely used and the answer depends on what outcome you’re measuring. An umbrella review synthesizing multiple meta-analyses found that intravenous diltiazem achieved better rate control than metoprolol, with a significantly greater drop in ventricular rate, particularly in the first 10 minutes. However, diltiazem also carried a higher risk of low blood pressure.¹¹ An earlier meta-analysis had similarly concluded that diltiazem lowered the heart rate more effectively and achieved rate control about a minute faster on average, with a modest edge in efficacy.¹²

On the other hand, a 2025 meta-analysis focused specifically on adverse events found that metoprolol was associated with roughly a quarter fewer overall side effects compared with diltiazem, with total adverse event rates of about 10% versus 19%. Neither drug showed a clear advantage in causing less bradycardia or less hypotension individually, but the composite safety picture favored metoprolol. The same study noted that patients with higher starting heart rates experienced more adverse events with either drug.¹³

In practice, the choice often comes down to the patient’s other medical conditions. Beta blockers like metoprolol are preferred in people with heart failure with reduced pumping function, because calcium channel blockers can further weaken heart muscle contraction. Diltiazem tends to be favored when faster rate control is needed and the patient’s blood pressure can tolerate it. Neither drug is universally superior.

The Wolff-Parkinson-White Exception

There is one clinical scenario where AF with RVR becomes immediately life-threatening, and it’s important enough to understand even as a layperson. In Wolff-Parkinson-White (WPW) syndrome, the heart has an extra electrical pathway connecting the atria and ventricles. Normally the AV node acts as a speed limit, preventing too many chaotic atrial signals from reaching the ventricles. The accessory pathway in WPW has no such speed limit. When a person with WPW develops AF, the rapid atrial signals can pour through the accessory pathway unfiltered, driving the ventricles at 250 or even 300 beats per minute. At those rates, the ventricles can degenerate into ventricular fibrillation, a cardiac arrest rhythm.¹⁴

What makes this scenario especially treacherous is that the standard rate-control drugs used for typical AF with RVR can make WPW worse. Medications that slow conduction through the AV node (like diltiazem, metoprolol, or digoxin) can inadvertently encourage more signals to travel through the accessory pathway, potentially accelerating the rate further. The treatment for pre-excited AF is different: procainamide, ibutilide, or emergency cardioversion. Recognizing the wide, irregular QRS pattern on the ECG is critical because giving the wrong drug can be fatal.¹⁵ This is one of the reasons the ECG interpretation steps described earlier place so much emphasis on evaluating QRS width and looking for WPW patterns.

After the Rate Comes Down

Once the immediate crisis is managed, two questions dominate the follow-up. The first is whether the patient needs blood thinners. AF, whether fast or controlled, allows blood to pool in the atria, forming clots that can travel to the brain and cause a stroke. Scoring systems like CHA₂DS₂-VASc help clinicians decide who needs anticoagulation, and direct oral anticoagulants are now the first-line choice for most patients.¹⁶ The decision about blood thinners is separate from the decision about rate or rhythm control and is based on stroke risk factors like age, prior stroke, high blood pressure, diabetes, and heart failure, not on whether the rate was fast during the initial episode.

The second question is disposition. Not every episode of AF with RVR leads to a hospital admission. An early feasibility study of an emergency department observation unit protocol for acute-onset AF found that about 81% of patients were discharged after an average of roughly 12 hours, while 19% needed inpatient admission after about 18 hours of observation.¹⁷ For many patients, especially those with a clear reversible trigger like a missed medication dose or a short bout of heavy drinking, a brief observation period with rate control and trigger correction is enough to go home safely with a plan for outpatient follow-up.

Paroxysmal Versus Persistent AF and the RVR Connection

The type of atrial fibrillation a person has influences how likely they are to experience RVR episodes. Paroxysmal AF, the kind that comes and goes on its own within seven days, was more prevalent among patients presenting with RVR in the Korean CODE-AF registry: about 53% of the RVR group had paroxysmal AF, compared with roughly 45% of the non-RVR group.¹ This makes intuitive sense. When AF is intermittent, each new episode hits the AV node with a sudden barrage of chaotic signals, and the heart rate surges before the body has time to adapt. In persistent AF, the AV node has been filtering those signals continuously and tends to settle into a somewhat lower, though still elevated, rate over time.

The same registry found that patients who presented with RVR also had a higher rate of atrial flutter at baseline, about 11% versus 6%. Atrial flutter is a related but more organized arrhythmia that sometimes coexists with AF. When both are present, the organized flutter waves can conduct to the ventricles at fixed ratios, sometimes producing very fast rates that feel abruptly different from the usual irregular AF pattern.

Wearable Devices and Catching RVR Outside the Hospital

One of the frustrating things about paroxysmal AF with RVR is that it can come and go before you ever get to a doctor. You feel the racing, the pounding, the breathlessness, and then it resolves on its own. By the time an ECG is performed, the rhythm looks perfectly normal. Wearable monitors are increasingly filling that detection gap. A study of cardiac surgery patients found that continuous monitoring with a patch-based wearable device after hospital discharge improved AF detection by about 18 percentage points compared with standard 12-lead ECG screening. Nearly three-quarters of those diagnosed were caught in the first week after surgery.¹⁸

Consumer smartwatches and ECG-capable wristbands have also entered the picture. While most of these devices can flag irregular rhythms, they are better at detecting the presence of AF than at quantifying how fast the ventricular rate is. If your watch alerts you to an irregular rhythm and you’re also experiencing symptoms like palpitations or dizziness, that combination is a strong reason to seek prompt medical evaluation rather than waiting for your next scheduled appointment. The technology is useful for catching episodes, but interpreting what they mean still belongs to a clinician with a full 12-lead ECG.

When RVR Looks Like Something Else

Not every fast irregular rhythm is AF with RVR, and the misdiagnosis rate is higher than many people assume. Multifocal atrial tachycardia, common in patients with severe lung disease, produces an irregular fast rhythm that can mimic AF on a quick glance at the monitor. Atrial flutter with variable block can also look irregular, though it tends to have a more “sawtooth” baseline pattern. Even sinus tachycardia with frequent premature beats can fool an untrained eye, particularly at very high rates where the P waves are hard to see.

The distinction matters because treatment differs for each. Giving a rate-control drug for what turns out to be sinus tachycardia in a dehydrated, septic patient could worsen their condition. Misidentifying atrial flutter may lead to ineffective drug choices. And as discussed earlier, mistaking pre-excited AF in WPW for ordinary AF with RVR can be fatal if the wrong medications are used. This is why emergency physicians emphasize careful ECG interpretation before reaching for a drug, even when the rate is alarmingly fast and the impulse to act immediately is strong.